Liver cancer in dogs is notoriously difficult to catch early because the liver has enormous functional reserve, meaning a tumor can grow for weeks or months before a dog shows any outward signs of illness. When symptoms do appear, they tend to be vague: decreased appetite, weight loss, lethargy, increased thirst, and occasional vomiting. These overlap with dozens of other conditions, which is why many liver tumors are discovered incidentally during routine bloodwork or an abdominal ultrasound performed for an unrelated concern. Understanding what to watch for and which dogs face higher risk can make the difference between catching a treatable tumor and finding one that has already spread.
Why Liver Cancer Stays Hidden So Long
The liver is one of the few organs that can keep working reasonably well even when a significant portion of its tissue is compromised. A tumor can occupy an entire lobe before the remaining healthy tissue can no longer compensate. This means the classic warning signs of liver disease, such as jaundice (yellowing of the gums, eyes, or skin), fluid buildup in the abdomen, or dramatic behavioral changes, often signal advanced disease rather than an early stage.
In the earliest phase, many dogs have no clinical signs at all. Their energy levels seem normal, they eat their food, and they act like themselves. The tumor may only show up as an unexpected finding on a blood panel run during a routine wellness visit or a pre-surgical screening. This is one of the strongest arguments for annual or twice-yearly blood panels in middle-aged and older dogs, even when they seem perfectly healthy.
The Signs That Do Show Up First
When early symptoms emerge, they are frustratingly nonspecific. The most commonly reported changes include:
- Appetite loss: Your dog may eat less, become picky, or skip meals entirely. This is one of the earliest behavioral shifts owners notice.
- Lethargy: A subtle decrease in activity, shorter walks, more napping, or less enthusiasm for play.
- Weight loss: Gradual, sometimes barely perceptible over weeks, but noticeable when you compare how your dog looks to a month or two earlier.
- Increased thirst and urination: Liver dysfunction can alter the body’s fluid balance, causing your dog to drink and urinate more than usual.
- Intermittent vomiting or diarrhea: Occasional gastrointestinal upset that comes and goes without an obvious trigger.
None of these on their own points clearly at the liver. A dog that skips a meal and seems tired for a day is probably fine. A dog that shows several of these signs consistently over a week or two warrants a vet visit, especially if the dog is over ten years old.
What Bloodwork Reveals Before Symptoms Appear
Routine blood panels are often the first place liver cancer leaves a trace. Two liver enzymes in particular tend to climb: ALT (alanine aminotransferase) and ALP (alkaline phosphatase). In dogs with hepatocellular carcinoma, the most common type of primary liver cancer, ALT levels have been found elevated roughly three to four times above normal and ALP elevated dramatically, sometimes more than fifteen times normal range.1PubMed Central. Size of canine hepatocellular carcinoma as an adverse prognostic factor for surgery Low albumin is another red flag that can appear on routine panels, reflecting the liver’s declining ability to produce this essential protein.
The catch is that elevated liver enzymes are not specific to cancer. They also rise with hepatitis, gallbladder disease, Cushing’s disease, and even certain medications. Your vet cannot look at a blood panel alone and say “this is cancer.” What elevated enzymes do is trigger the next step: imaging. And that is where the picture starts to sharpen.
One blood marker that shows more promise for distinguishing cancer from other liver problems is alpha-fetoprotein, or AFP. In healthy dogs, serum AFP stays below about 70 ng/mL. In a study measuring AFP in dogs with various liver diseases, seven of nine dogs with hepatocellular carcinoma had levels above 1,400 ng/mL, while dogs with non-cancerous liver disease stayed below 500 ng/mL in the vast majority of cases.2PubMed. Serum alpha-fetoprotein values in dogs with various hepatic diseases After surgical removal of the tumor, AFP levels dropped back to normal in dogs whose cancer was successfully resected, reinforcing that the tumor itself was driving the elevation.3PubMed. Alpha-fetoprotein in serum and tumor tissues in dogs with hepatocellular carcinoma AFP testing is not yet a standard part of every wellness panel, but it may be worth discussing with your vet if your dog has suspicious liver enzyme elevations and fits the demographic profile for liver cancer.
Imaging and How Tumors Are Found
Abdominal ultrasound is typically the first imaging tool a vet reaches for when bloodwork suggests liver trouble. It can detect masses, changes in liver texture, and abnormalities in surrounding organs. A study comparing ultrasound findings with biopsy results in 138 dogs found that the presence of a hepatic mass was significantly associated with a diagnosis of neoplasia. But the same study also found that about two-thirds of livers that looked normal on ultrasound actually had histologic abnormalities when biopsied.4PubMed. A comparison of hepatic sonographic features and histopathologic diagnosis in canine liver disease: 138 cases In other words, a clean-looking ultrasound does not completely rule out early-stage disease.
When a mass is found, its ultrasound appearance offers some clues about what it might be. A review of 48 dogs with hepatic tumors found that a single focal mass was almost always hepatocellular carcinoma (14 of 15 cases), and most of these masses appeared brighter than the surrounding liver tissue on ultrasound.5PubMed. Ultrasonographic appearance of primary and metastatic canine hepatic tumors. A review of 48 cases For dogs with multiple liver lesions, ultrasound scoring systems that assess the overall texture and pattern of the liver have shown high accuracy in distinguishing benign from malignant disease, with one system achieving roughly 98% accuracy in identifying malignant multifocal lesions.6PubMed Central. Predictive Factors of Canine Malignant Hepatic Diseases with Multifocal Hepatic Lesions Using Clinicopathology, Ultrasonography, and Hepatobiliary Ultrasound Scores
CT scans provide more detailed information, especially for surgical planning. A meta-analysis of CT features in canine liver lesions found that larger size, heterogeneous appearance after contrast injection, and lower density compared to surrounding liver tissue were all more associated with malignancy.7PubMed. Computed tomography features for differentiating malignant and benign focal liver lesions in dogs: A meta-analysis One study found that masses larger than about 4.5 cm in diameter on CT were far more likely to be malignant, with an overall diagnostic accuracy approaching 89%.8PubMed Central. Computed tomographic features for differentiating benign from malignant liver lesions in dogs CT is also used to determine exactly which liver lobe the mass occupies, which is critical information if surgery is on the table.
Types of Primary Liver Cancer in Dogs
Primary liver cancer, meaning cancer that originates in the liver rather than spreading there from another organ, is relatively uncommon in dogs.9PubMed Central. Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs When it does occur, hepatocellular carcinoma is by far the most frequent subtype. It arises from the liver’s main functional cells and typically presents as a single large mass confined to one lobe. An early clinicopathologic study noted that a massive lesion in a single lobe, most often the left lateral lobe, was the most common pattern for both hepatocellular carcinoma and bile duct carcinoma.10PubMed. Canine hepatic neoplasms: a clinicopathologic study
Bile duct carcinoma (cholangiocarcinoma) is less common and tends to be more aggressive. It arises from the cells lining the bile ducts within the liver. Neuroendocrine carcinomas are rarer still, and they can produce unusual symptoms because they sometimes secrete hormones. In one reported case, a primary hepatic neuroendocrine carcinoma produced insulin, leading to dangerously low blood sugar and seizures, symptoms that initially had nothing obviously to do with the liver.11PubMed Central. Hypoglycemia and seizures associated with canine primary hepatic neuroendocrine carcinoma These hormone-secreting tumors are rare, but they illustrate how liver cancer can occasionally present with symptoms that don’t seem liver-related at all.
It is worth noting that the liver is a common landing site for cancers that originate elsewhere in the body. Metastatic liver tumors, which spread from cancers in the spleen, pancreas, intestines, or other organs, are actually more common than primary liver tumors in dogs. The distinction matters enormously for prognosis and treatment: a single primary mass in one lobe can often be surgically removed with good outcomes, while diffuse metastatic disease throughout the liver is a very different situation.
Which Dogs Are Most at Risk
Age is the strongest risk factor. Liver cancer is overwhelmingly a disease of older dogs. A large retrospective study of massive hepatocellular carcinoma found that each additional year of age increased the odds of being diagnosed with the tumor, with an odds ratio of 1.20 per year. The same study identified breed predispositions: Welsh Corgis had roughly 3.7 times the odds, and Beagles had about 4.3 times the odds compared to the general dog population.12PubMed. Epidemiology of massive hepatocellular carcinoma in dogs: A 4-year retrospective study
The underlying causes of primary liver cancer in dogs are poorly understood. Unlike in humans, where chronic hepatitis and cirrhosis account for a large share of liver cancer cases, most dogs with hepatocellular carcinoma do not have a history of chronic hepatitis. Research into hepatic copper levels in dogs with liver cancer found that some dogs had mild copper accumulation in their liver tissue, but the levels were far below what is typically seen in copper-associated hepatitis. Whether low-level trace mineral imbalances contribute to cancer development through oxidative stress remains an open question.13Journal of Veterinary Internal Medicine. Hepatic copper and other trace mineral concentrations in dogs with hepatocellular carcinoma Environmental exposures, diet, and genetic factors are all suspected to play roles, but none has been definitively linked to liver cancer development in dogs.
What Happens After a Mass Is Found
Finding a liver mass on imaging is not the same as confirming cancer. Benign growths like nodular hyperplasia and hepatocellular adenomas are common in older dogs and can look similar to malignant tumors on ultrasound or even CT. The definitive step is tissue sampling, either through fine-needle aspiration or a needle core biopsy performed under ultrasound guidance. Fine-needle aspiration is less invasive and works well for some tumor types, while core biopsy provides a larger tissue sample that allows for more detailed analysis, including immunohistochemistry staining that helps classify exactly what kind of tumor is present.14PubMed. For diagnosis of liver masses, fine-needle aspiration versus needle core biopsy: which is better?
In some cases, rather than biopsying a suspicious mass first, the veterinary surgeon may recommend going straight to surgery if imaging strongly suggests a solitary hepatocellular carcinoma in a lobe that can be safely removed. This approach, called liver lobectomy, removes the entire affected lobe along with the mass. For dogs with a single large mass, outcomes can be remarkably good: in one study of dogs undergoing liver lobectomy for tumors, 93% survived to hospital discharge, and the median survival time was not reached during the study period, meaning more than half the dogs were still alive when data collection ended.15PubMed Central. Factors associated with long-term survival in dogs undergoing liver lobectomy as treatment for liver tumors That is an encouraging number, but it reflects a selected group of dogs with operable tumors. Dogs with diffuse or metastatic disease face a much different outlook.
Paraneoplastic Syndromes and Unusual Presentations
A small but important subset of liver cancers cause symptoms through indirect mechanisms called paraneoplastic syndromes. These occur when a tumor produces substances that affect other parts of the body. The most dramatic example in dogs is hypoglycemia, where a liver tumor produces insulin or insulin-like substances, causing blood sugar to crash. A dog experiencing paraneoplastic hypoglycemia may show sudden weakness, disorientation, trembling, or seizures. An owner witnessing these episodes might reasonably assume their dog has epilepsy or a neurological problem, not liver cancer.
These presentations are uncommon, but they matter because they can delay diagnosis. If your older dog has unexplained seizures or episodes of collapse, especially if bloodwork shows persistently low blood sugar, your vet should consider liver masses as a possible cause.
Practical Steps for Dog Owners
Because early liver cancer so rarely announces itself through behavior changes alone, proactive screening is the most realistic path to early detection. For dogs over eight years old, annual wellness bloodwork that includes a full chemistry panel with liver enzymes (ALT, ALP, GGT) and albumin gives you a baseline and a way to track trends over time. A single slightly elevated liver enzyme is not cause for panic, but a pattern of rising values over consecutive visits is worth pursuing with imaging.
If your dog belongs to a higher-risk breed, or if you notice a combination of the soft signs described earlier, lowered appetite, unexplained weight loss, increased thirst, or unusual lethargy, don’t wait for the next scheduled wellness visit. An earlier blood panel and abdominal ultrasound can catch problems while they are still surgically approachable. The difference between a solitary mass that can be removed and one that has started to spread can come down to a matter of weeks.
For dogs already diagnosed with cancer and undergoing chemotherapy, the liver deserves extra attention. Some chemotherapy drugs, particularly lomustine (CCNU), are known to cause liver damage. A clinical trial showed that dogs receiving CCNU alone had elevated liver enzymes in 84% of cases, and were more likely to need treatment delays or discontinuation due to liver toxicity. Dogs given a liver-protective supplement alongside CCNU had somewhat lower rates of enzyme elevation and less severe changes in liver function markers.16Journal of Veterinary Internal Medicine. Prospective Randomized Clinical Trial Assessing the Efficacy of Denamarin for Prevention of CCNU-Induced Hepatopathy in Tumor-Bearing Dogs If your dog is on chemotherapy, regular monitoring of liver values is standard practice, and your oncologist may recommend hepatoprotective supplements as part of the treatment plan.
How CT Helps With Surgical Planning
When surgery is being considered, knowing exactly where the tumor sits within the liver matters enormously. The liver has multiple lobes, and not all are equally accessible to a surgeon. CT scanning before surgery aims to localize the mass to a specific lobe and help the surgical team plan their approach. A study evaluating how accurately four board-certified radiologists could pinpoint tumor location on CT found an overall accuracy of about 74% by specific lobe and 88% when categorized by broader liver division. Accuracy was highest for tumors in the left lateral lobe, close to 90%, and lowest for those in the quadrate lobe, just over 40%.17PubMed Central. Computed tomography scan accuracy for the prediction of lobe and division of liver tumors by four board-certified radiologists These numbers reinforce that while CT is a valuable planning tool, surgeons sometimes encounter a different situation than expected once they are inside.
For owners, the practical takeaway is that a pre-surgical CT is standard before liver lobectomy, and the results directly influence whether surgery is recommended. A tumor in the left lateral lobe, which is the most common site for hepatocellular carcinoma, is generally the most straightforward to remove. Tumors in certain central lobes present more surgical challenges due to their proximity to major blood vessels. Your veterinary surgeon will weigh the CT findings against your dog’s overall health, age, and anesthetic risk to determine whether the potential benefits of surgery outweigh the risks.